Jonathan Yong
Stock Analyst at UBS
(2.62)
# 2,152
Out of 4,944 analysts
107
Total ratings
60.71%
Success rate
10.42%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $3.46 | +44.51% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $2.50 | +20.00% | 4 | Aug 6, 2025 | |
| OSCR Oscar Health | Downgrades: Sell | $15 → $11 | $14.98 | -26.57% | 8 | Jul 15, 2025 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $24.02 | +4.08% | 2 | Aug 24, 2023 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $33 → $30 | $11.87 | +152.74% | 5 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $7.54 | +59.15% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $3.50 | +128.57% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $12.76 | +103.76% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $47.96 | -70.81% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $67.52 | +42.18% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $32 | $12.40 | +158.06% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $17.64 | +495.24% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $118.63 | -32.56% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $269.31 | -14.23% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $100.95 | +0.05% | 5 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $6.87 | +293.01% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $146.30 | -31.65% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $659.01 | -31.72% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $3.60 | +233.80% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $7.06 | +891.50% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $14.85 | +14.52% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $157.31 | +122.49% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $20.33 | +367.29% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $5.82 | +46.05% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $20.71 | +97.97% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $5.47 | +210.79% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $2.56 | +232.03% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $80.78 | +5.22% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $178.68 | -18.29% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $26.17 | +305.04% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $175.21 | -10.39% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $280.47 | +31.21% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $274.94 | +130.96% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $65.51 | +78.60% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $14.72 | +103.80% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $390.31 | -23.65% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $170.48 | -44.27% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $261.57 | +89.24% | 1 | Oct 15, 2021 |
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $3.46
Upside: +44.51%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $2.50
Upside: +20.00%
Oscar Health
Jul 15, 2025
Downgrades: Sell
Price Target: $15 → $11
Current: $14.98
Upside: -26.57%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $24.02
Upside: +4.08%
Walgreens Boots Alliance
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $30
Current: $11.87
Upside: +152.74%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $7.54
Upside: +59.15%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $3.50
Upside: +128.57%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $12.76
Upside: +103.76%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $47.96
Upside: -70.81%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $67.52
Upside: +42.18%
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $12.40
Upside: +158.06%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $17.64
Upside: +495.24%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $118.63
Upside: -32.56%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $269.31
Upside: -14.23%
Jul 27, 2023
Reiterates: Neutral
Price Target: $101
Current: $100.95
Upside: +0.05%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $6.87
Upside: +293.01%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $146.30
Upside: -31.65%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $659.01
Upside: -31.72%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $3.60
Upside: +233.80%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $7.06
Upside: +891.50%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $14.85
Upside: +14.52%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $157.31
Upside: +122.49%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $20.33
Upside: +367.29%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $5.82
Upside: +46.05%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $20.71
Upside: +97.97%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $5.47
Upside: +210.79%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $2.56
Upside: +232.03%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $80.78
Upside: +5.22%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $178.68
Upside: -18.29%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $26.17
Upside: +305.04%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $175.21
Upside: -10.39%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $280.47
Upside: +31.21%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $274.94
Upside: +130.96%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $65.51
Upside: +78.60%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $14.72
Upside: +103.80%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $390.31
Upside: -23.65%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $170.48
Upside: -44.27%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $261.57
Upside: +89.24%